Yale

Articles

Yale Cancer Center Study Shows Stem-Like T Cells Could Aid Immunotherapy in Cancer Treatment

September 20th 2021

In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters.

Lakshmanan Krishnamurti Named Chief of Pediatric Hematology, Oncology, and Bone Marrow Transplant at Yale New Haven Children’s Hospital and Smilow Cancer Hospital

July 29th 2021

Lakshmanan Krishnamurti, MD, has been named Chief of Pediatric Hematology, Oncology, and Bone Marrow Transplant at Yale New Haven Children’s Hospital and Leader of the Smilow Cancer Hospital Pediatric Hematology/Oncology Program.

Yale Cancer Center Laboratory Study Shows Combination Treatment Effective in IDH-Mutant Cancers

July 2nd 2021

A new study led by Yale Cancer Center scientists revealed the combination of ATR and PARP inhibitor therapies can effectively target the enzyme isocitrate dehydrogenase-I/2 (IDH-1/2) in mutant cancer cells.

Barbara Burtness Named Interim Associate Director for Diversity, Equity, and Inclusion at Yale Cancer Center

June 30th 2021

Barbara Burtness, MD, has been appointed Interim Associate Director for Diversity, Equity, and Inclusion at Yale Cancer Center.

Yale Cancer Center Study Reveals New Pathway for Brain Tumor Therapy

June 17th 2021

Researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Yale Cancer Center Study Shows Novel Test Can Detect New and Recurrent Bladder Cancer

June 11th 2021

A revolutionary new urine screening test that utilizes a novel Keratin 17 cancer biomarker can detect the presence of new bladder cancer in patients with hematuria, or blood in the urine.

Yale Cancer Center Study Shows Cognitive Impairment for Survivors of Many Pediatric Cancers

May 14th 2021

In a new study led by Yale Cancer Center, researchers report many survivors of childhood cancers receive systemic therapies associated with cognitive effects and chronic health conditions that may impact long-term cognitive outcomes with downstream effects on education, employment, and income.

Cancer and Tobacco Experts Not Fired Up about E-Cigarettes for Quitting Smoking

January 8th 2015

Leading experts in cancer research and tobacco policy are not ready to recommend electronic nicotine delivery systems, like e-cigarettes, as a safe way to quit smoking.